USD 0.33
(8.36%)
Breakdown | 2024 | 2024 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 28.93 Billion | 28.93 Billion | 31.87 Billion | 36 Billion | 33.69 Billion | 32.56 Billion |
Cost of Revenue | 16.85 Billion | 16.85 Billion | 18.05 Billion | 21.32 Billion | 19.5 Billion | 18.95 Billion |
Gross Profit | 12.08 Billion | 12.08 Billion | 13.82 Billion | 14.68 Billion | 14.18 Billion | 13.6 Billion |
Operating Expenses | 9.29 Billion | 9.29 Billion | 10.39 Billion | 10.66 Billion | 10.86 Billion | 10.33 Billion |
Selling, General and Administrative Expenses | 9.47 Billion | 9.47 Billion | 10.73 Billion | 10.89 Billion | 11.05 Billion | 9.48 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -177.1 Million | -175.9 Million | - | - | - | 1.1 Million |
Cost and Expenses | 26.14 Billion | 26.14 Billion | 28.44 Billion | 31.99 Billion | 30.36 Billion | 29.29 Billion |
Operating Income | 2.78 Billion | 2.78 Billion | 3.43 Billion | 3.98 Billion | 3.3 Billion | 3.23 Billion |
Interest Expense | 147.3 Million | 147.3 Million | 217.8 Million | 279.3 Million | 272.1 Million | 211.2 Million |
Income Tax Expense | 547.9 Million | 547.9 Million | 879.6 Million | 1.08 Billion | 782.7 Million | 845.5 Million |
Earnings before Tax | 2.75 Billion | 2.75 Billion | 3.32 Billion | 3.85 Billion | 3.08 Billion | 3.04 Billion |
Net Income | 2.21 Billion | 2.21 Billion | 2.44 Billion | 2.77 Billion | 2.3 Billion | 2.19 Billion |
Earnings Per Share Basic | 0.36 | 0.36 | 0.39 | 0.45 | 0.41 | 0.35 |
Earnings Per Share Diluted | 0.36 | 0.36 | 0.39 | 0.45 | 0.41 | 0.35 |
Weighted Average Shares Outstanding | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion |
Weighted Average Shares Outstanding (Diluted) | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion |
Gross Margin | 0.42 | 0.42 | 0.43 | 0.41 | 0.42 | 0.42 |
EBIT Margin | 0.16 | 0.16 | 0.19 | 0.19 | 0.17 | 0.16 |
Profit Margin | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 |
EBITDA | 4.57 Billion | 4.57 Billion | 6.07 Billion | 6.76 Billion | 5.86 Billion | 5.32 Billion |
Earnings Before Tax Margin | 0.10 | 0.10 | 0.11 | 0.11 | 0.10 | 0.10 |
Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 28.93 Billion | 2.03 Billion | 2 Billion | 1.97 Billion | 27.07 Billion | 1.99 Billion |
Cost of Revenue | 16.85 Billion | 1.36 Billion | 1.22 Billion | 1.38 Billion | 15.78 Billion | 1.25 Billion |
Gross Profit | 12.08 Billion | 677.39 Million | 778.37 Million | 592.08 Million | 11.28 Billion | 741.33 Million |
Operating Expenses | 9.29 Billion | 543.18 Million | 532.53 Million | 477.73 Million | 8.85 Billion | 528.4 Million |
Selling, General and Administrative Expenses | - | 543.18 Million | 532.53 Million | 477.73 Million | - | 528.4 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 26.14 Billion | 1.9 Billion | 1.75 Billion | 1.85 Billion | 24.64 Billion | 1.78 Billion |
Operating Income | 2.78 Billion | 134.21 Million | 245.84 Million | 114.34 Million | 2.43 Billion | 212.93 Million |
Interest Expense | 147.3 Million | 9.59 Million | 11.01 Million | 14.22 Million | 211.2 Million | 16.79 Million |
Income Tax Expense | 547.9 Million | 24.46 Million | 52.42 Million | 16.15 Million | 485.8 Million | 56.2 Million |
Earnings before Tax | 2.75 Billion | 145.32 Million | 241.34 Million | 114.6 Million | 2.32 Billion | 229.08 Million |
Net Income | 2.21 Billion | 121.02 Million | 188.99 Million | 98.45 Million | 1.83 Billion | 172.87 Million |
Earnings Per Share Basic | - | 0.02 | 0.03 | 0.02 | - | 0.03 |
Earnings Per Share Diluted | - | 0.02 | 0.03 | 0.02 | - | 0.03 |
Weighted Average Shares Outstanding | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion |
Weighted Average Shares Outstanding (Diluted) | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion | 6.2 Billion |
Gross Margin | 0.42 | 0.33 | 0.39 | 0.30 | 0.42 | 0.37 |
EBIT Margin | - | 0.12 | 0.18 | 0.14 | - | 0.19 |
Profit Margin | 0.08 | 0.06 | 0.09 | 0.05 | 0.07 | 0.09 |
EBITDA | - | 250.04 Million | 363.66 Million | 270.56 Million | - | 381.82 Million |
Earnings Before Tax Margin | 0.10 | 0.07 | 0.12 | 0.06 | 0.09 | 0.11 |
MAGADSUGAR
EXCELINDUS
AARTIPHARM
CTN
DKM
4265